Teva Pharmaceutical Reaches Fourth U.S. Settlement Over Price-Fixing Claims
October 07 2022 - 09:18AM
Dow Jones News
By Sabela Ojea
Teva Pharmaceutical Industries Ltd. said Friday that it reached
a settlement agreement with Arkansas's attorney general over
price-fixing claims, taking the number of settlements closed with
an U.S. attorney general to four.
The Israeli pharmaceutical company said that it agreed to pay
the state of Arkansas $931,000 over the same claims, which it
continues to deny.
The state will dismiss all claims against the company and its
affiliates once the transaction has been made, Teva said.
Teva's latest deal with an U.S. attorney general comes only a
week after the company agreed to pay the state of Georgia $53
million. Teva previously signed other settlement agreements with
Mississippi and Louisiana.
Write to Sabela Ojea at sabela.ojea@wsj.com
(END) Dow Jones Newswires
October 07, 2022 09:03 ET (13:03 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Feb 2023 to Mar 2023
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Mar 2022 to Mar 2023